FIELD: medicine.
SUBSTANCE: nidus is sanitised with air-plasma flow containing nitrogen oxide from distance 20-25 cm. Each area of nidus sized 1cm x 1cm is exposed for 8-9 seconds. Total exposure time corresponds to wound area. Then wound surface as covered with gel as medicinal agent during I and II phase of wound process. Gel contains myelopid concentrated 3000 mcg/ml - 66 ml, aerosyl - 7.5 g, glycerin - 26.5 g. Gel covers total wound surface.
EFFECT: method enables to reduce inflammatory process course and increase regenerative processes due to myelopid application.
2 ex, 2 cl
Title | Year | Author | Number |
---|---|---|---|
MEDICINE WITH ANTICANDIDOSIS EFFECT | 2006 |
|
RU2333765C1 |
PURULENT WOUND HEALING TECHNIQUE | 2008 |
|
RU2409372C2 |
METHOD FOR PREVENTION OF PERITONEAL ADHESIONS | 2011 |
|
RU2523263C2 |
METHOD FOR TREATING THE CASES OF OSTEOMYELITIS | 2002 |
|
RU2221573C1 |
METHOD OF TREATING PATIENTS SUFFERING FROM COMPLICATED FORMS OF ERYSIPELAS | 2014 |
|
RU2546039C1 |
METHOD FOR TREATING PROLONGED TROPHIC ULCERS | 2001 |
|
RU2195930C2 |
METHOD FOR COMBINED TREATMENT OF TROPHIC ULCERS WITH MULTIRESISTANT MICROFLORA IN DIABETIC FOOT SYNDROME | 2021 |
|
RU2782801C1 |
METHOD OF TREATMENT OF PURULENT-NECROTIC FORM OF ERYSIPILATOUS INFLAMMATION | 2007 |
|
RU2343855C1 |
METHOD OF TREATMENT OF INFECTIOUS COMPLICATIONS AFTER CARDIAC-VASCULAR INTERVENTIONS | 2017 |
|
RU2647624C1 |
METHOD FOR TREATING ABSCESSES, SOFT TISSUE PHLEGMONS | 2006 |
|
RU2284825C1 |
Authors
Dates
2008-06-20—Published
2006-11-28—Filed